Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment

Polycaprolactone (PCL)is a biodegradable polymer that is widely utilized for biomedical applications, as well as for environmentally sustainable packaging. The mechanisms driving PCL degradation appear to be overall variably documented and investigated, despite the potentially significant influence that aspects such as synthesis, end-group chemistry, molecular weight, and crystallinity, both before and after melt processing, may have on the behavior of the polymer over time. In this review, we identify mechanisms of PCL degradation across a range of mainly biomedical applications, exploring the role of the polymer structure and form, radical interactions, temperature, pH, enzymatic activity, and cellular phagocytosis. We examine how polymer chemistry has been used to alter PCL degradation rates and mechanisms, and present cases where such manipulations may affect the applications of PCL. We also comprehensively discuss the literature assessing the degradation of PCL in vitro and in vivo, and present a summary of the correlations and trends between the data. Significantly, our analysis identifies currently undescribed trends in PCL degradation. Namely, we observe that molecular weight decreases at a consistent rate regardless of the initial value, and does so at a linear rate in vitro and an exponential rate in vivo. Both mechanical properties and mass loss are strongly influenced by construct geometry and environmental conditions. We further assess the current biomedical literature on the degradation of PCL copolymers and its composites. The formation of novel PCL copolymers or composites is often used to broaden the versatility and applicability of the polymer, although this approach is rarely explored beyond initial research. Novel biomaterials overall rarely emerge from research, with inherent issues such as the reproducibility of synthesis, manufacturing, or characterization methods and outcomes further impeding their translation. We conclude the review with a summary of the current state of the tailorability of PCL-based polymers and composites, and offer recommendations for the future research direction of the field.

[1]  R. Gross,et al.  Hydrolytic degradation of PCL/PEO copolymers in alkaline media , 2000, Journal of materials science. Materials in medicine.

[2]  J. Lee,et al.  Analysis of degradation rate for dimensionless surface area of well-interconnected PCL scaffold via in-vitro accelerated degradation experiment , 2014, Tissue Engineering and Regenerative Medicine.

[3]  D. Farrar,et al.  Accelerated degradation behaviour of poly(ɛ-caprolactone) via melt blending with poly(aspartic acid-co-lactide) (PAL) , 2009 .

[4]  P. Teyssié,et al.  Study of poly-ϵ-caprolactone bulk degradation , 1976 .

[5]  H. C. Bennet-Clark,et al.  The Mechanical Properties of Biological Materials , 2012 .

[6]  G. Madras,et al.  Kinetics of thermal degradation of poly(ε-caprolactone) , 2003 .

[7]  Dietmar W. Hutmacher,et al.  Development of perforated microthin poly(ε-caprolactone) films as matrices for membrane tissue engineering , 2004, Journal of biomaterials science. Polymer edition.

[8]  A. Vidaurre,et al.  A comparative study on Poly(ε-caprolactone) film degradation at extreme pH values , 2016 .

[9]  W. Punyodom,et al.  Kinetics and thermodynamics analysis for ring-opening polymerization of ε-caprolactone initiated by tributyltin n-butoxide using differential scanning calorimetry , 2014, Journal of Thermal Analysis and Calorimetry.

[10]  Dietmar W Hutmacher,et al.  Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions , 2008, Biomedical materials.

[11]  R. Morent,et al.  Effects of different sterilization methods on the physico-chemical and bioresponsive properties of plasma-treated polycaprolactone films , 2017, Biomedical materials.

[12]  N. Ayed,et al.  Characterization of plastic packaging additives: Food contact, stability and toxicity , 2017 .

[13]  S. Teoh,et al.  The degradation profile of novel, bioresorbable PCL-TCP scaffolds: an in vitro and in vivo study. , 2008, Journal of biomedical materials research. Part A.

[14]  X. Jing,et al.  Enzymatic degradation of poly(ε-caprolactone)/poly(dl-lactide) blends in phosphate buffer solution , 1999 .

[15]  Guanwei Fan,et al.  Small-diameter hybrid vascular grafts composed of polycaprolactone and polydioxanone fibers , 2017, Scientific Reports.

[16]  M. Vallet‐Regí,et al.  Vascular endothelial and smooth muscle cell culture on NaOH-treated poly(epsilon-caprolactone) films: a preliminary study for vascular graft development. , 2005, Macromolecular bioscience.

[17]  J. A. Hubbell,et al.  Rapidly degraded terpolymers of dl-lactide, glycolide, and epsilon-caprolactone with increased hydrophilicity by copolymerization with polyethers. , 1990, Journal of biomedical materials research.

[18]  N. Bölgen,et al.  In vitro and in vivo degradation of non-woven materials made of poly(ε-caprolactone) nanofibers prepared by electrospinning under different conditions , 2005, Journal of biomaterials science. Polymer edition.

[19]  S. Pogwizd,et al.  Fibro-porous poliglecaprone/polycaprolactone conduits: synergistic effect of composition and in vitro degradation on mechanical properties. , 2015, Polymer international.

[20]  A. Shojaei,et al.  Fabrication and Properties of Polycaprolactone Composites Containing Calcium Phosphate-Based Ceramics and Bioactive Glasses in Bone Tissue Engineering: A Review , 2018 .

[21]  Patrina S P Poh,et al.  Data for accelerated degradation of calcium phosphate surface-coated polycaprolactone and polycaprolactone/bioactive glass composite scaffolds , 2016, Data in brief.

[22]  A. Schindler,et al.  Aliphatic polyesters. I. The degradation of poly(ϵ‐caprolactone) in vivo , 1981 .

[23]  J. Sarasua,et al.  Hydrolytic degradation and bioactivity of lactide and caprolactone based sponge-like scaffolds loaded with bioactive glass particles , 2014 .

[24]  S. Agarwal Chemistry, chances and limitations of the radical ring-opening polymerization of cyclic ketene acetals for the synthesis of degradable polyesters , 2010 .

[25]  J. Jung,et al.  Acid- and base-catalyzed hydrolyses of aliphatic polycarbonates and polyesters , 2006 .

[26]  R. Storey,et al.  Kinetics and Mechanism of the Stannous Octoate-Catalyzed Bulk Polymerization of ∊-Caprolactone , 2002 .

[27]  C. G. Pitt Poly-ε-caprolactone and its copolymers , 1990 .

[28]  G. Camino,et al.  Biodegradation trend of poly(ε-caprolactone) and nanocomposites , 2010 .

[29]  W. F. Kimbrough,et al.  Susceptibility of a polycaprolactone-based root canal filling material to degradation. I. Alkaline hydrolysis. , 2005, Journal of endodontics.

[30]  R. Legras,et al.  Physico-mechanical properties of poly (epsilon-caprolactone) for the construction of rumino-reticulum devices for grazing animals. , 1995, Biomaterials.

[31]  E. Pamuła,et al.  Hydrolytic degradation of porous scaffolds for tissue engineering from terpolymer of l-lactide, ε-caprolactone and glycolide , 2005 .

[32]  S. Saha,et al.  Effects of rapid crystallization on hydrolytic degradation and mechanical properties of poly(l-lactide-co-ε-caprolactone) , 2006 .

[33]  Hsieh-Chih Tsai,et al.  In vivo degradation of poly (ε-caprolactone) films in Gastro Intestinal (GI) tract , 2017 .

[34]  Chad Johnson,et al.  The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. , 2004, Biomaterials.

[35]  Katrin Mackenzie,et al.  Thermal decomposition of biodegradable polyesters—II. Poly(lactic acid) , 1996 .

[36]  D W L Hukins,et al.  Accelerated aging for testing polymeric biomaterials and medical devices. , 2008, Medical engineering & physics.

[37]  Suming Li,et al.  Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. , 1995, Biomaterials.

[38]  M. Vert,et al.  Structural characterization and hydrolytic degradation of solid copolymers of d,l-lactide-co-ε-caprolactone by Raman spectroscopy , 2000 .

[39]  P. Bártolo,et al.  Evaluation of in vitro degradation of PCL scaffolds fabricated via BioExtrusion. Part 1: Influence of the degradation environment , 2010 .

[40]  B. Marí,et al.  Hydrolytic and enzymatic degradation of a poly(ε-caprolactone) network , 2012 .

[41]  Scott J Hollister,et al.  Additive manufacturing of polymer melts for implantable medical devices and scaffolds , 2017, Biofabrication.

[42]  Shaun Eshraghi,et al.  Mechanical and microstructural properties of polycaprolactone scaffolds with one-dimensional, two-dimensional, and three-dimensional orthogonally oriented porous architectures produced by selective laser sintering. , 2010, Acta biomaterialia.

[43]  Pietro Favia,et al.  Improved osteoblast cell affinity on plasma-modified 3-D extruded PCL scaffolds. , 2013, Acta biomaterialia.

[44]  R. Wehrenberg Lactic acid polymers: strong, degradable thermoplastics , 1981 .

[45]  X. Jing,et al.  Enzymatic degradation of poly(ε-caprolactone) film in phosphate buffer solution containing lipases , 1997 .

[46]  J. Eguiazábal,et al.  Structure and mechanical properties of blends of poly(ε‐caprolactone) with a poly(amino ether) , 2008 .

[47]  G L Kimmel,et al.  Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. , 1981, Biomaterials.

[48]  Joanna Rydz,et al.  Polyester-Based (Bio)degradable Polymers as Environmentally Friendly Materials for Sustainable Development , 2014, International journal of molecular sciences.

[49]  J. Valentine,et al.  Cleavage of esters by superoxide , 1976 .

[50]  Dong-Woo Cho,et al.  Investigation of thermal degradation with extrusion-based dispensing modules for 3D bioprinting technology , 2016, Biofabrication.

[51]  N. Scharnagl,et al.  Poly(lactones). 9. Polymerization mechanism of metal alkoxide initiated polymerizations of lactide and various lactones , 1988 .

[52]  F. Kopinke,et al.  Mechanistic aspects of the thermal degradation of poly(lactic acid) and poly(β-hydroxybutyric acid) , 1997 .

[53]  M. Xanthos,et al.  Degradation of Aliphatic Polyesters in the Presence of Inorganic Fillers , 2007 .

[54]  P. Dubois,et al.  Mechanisms and Kinetics of Thermal Degradation of Poly(ε-caprolactone) , 2001 .

[55]  Hyoun‐Ee Kim,et al.  Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[56]  Young Ha Kim,et al.  In vivo biocompatibilty and degradation behavior of elastic poly(l-lactide-co-ε-caprolactone) scaffolds , 2004 .

[57]  G. Madras,et al.  Enzymatic and Thermal Degradation of Poly(epsilon-caprolactone), Poly(D,L-lactide), and Their Blends , 2004 .

[58]  Y. Ikada,et al.  Biodegradable polyesters for medical and ecological applications , 2000 .

[59]  Swee Hin Teoh,et al.  Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. , 2009, Journal of biomedical materials research. Part A.

[60]  C. Shih Chain-end scission in acid catalyzed hydrolysis of poly (d,l-lactide) in solution , 1995 .

[61]  M. Kohno,et al.  Investigation of reactive species using various gas plasmas , 2014 .

[62]  Min He,et al.  Drug loaded homogeneous electrospun PCL/gelatin hybrid nanofiber structures for anti-infective tissue regeneration membranes. , 2014, Biomaterials.

[63]  G. Madras,et al.  Solvent effects on the lipase catalyzed biodegradation of poly (ε-caprolactone) in solution , 2003 .

[64]  C. Nicolini,et al.  Lipase-catalyzed degradation of poly(ε-caprolactone) , 2004 .

[65]  M. Sedlačík,et al.  Photochemically cross-linked poly(ε-caprolactone) with accelerated hydrolytic degradation , 2015 .

[66]  Dehong Chen,et al.  Polycaprolactone microparticles and their biodegradation , 2000 .

[67]  T. Karjalainen,et al.  Biodegradable lactone copolymers.II.Hydrolytic study of e-caprolactone and lactide copolymers , 1996 .

[68]  W. Tan,et al.  Effect of porosity on long-term degradation of poly (ε-caprolactone) scaffolds and their cellular response , 2013 .

[69]  Benjamin J. McCoy,et al.  Peroxide enhancement of poly(α-methylstyrene) thermal degradation , 2001 .

[70]  A. Albertsson,et al.  The biodegradation of amorphous and crystalline regions in film-blown poly(ε-caprolactone) , 2000 .

[71]  I Zein,et al.  Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. , 2001, Journal of biomedical materials research.

[72]  Benjamin M. Wu,et al.  Lamellar stack formation and degradative behaviors of hydrolytically degraded poly(ε-caprolactone) and poly(glycolide-ε-caprolactone) blended fibers. , 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

[73]  John G. Lyons,et al.  In vitro degradation and drug release from polymer blends based on poly(dl-lactide), poly(l-lactide-glycolide) and poly(ε-caprolactone) , 2010 .

[74]  G. Madras,et al.  Oxidative degradation of poly (vinyl acetate) and poly (ε-caprolactone) and their mixtures in solution , 2004 .

[75]  L. Malinová,et al.  Ethyl magnesium bromide as an efficient anionic initiator for controlled polymerization of ε-caprolactone , 2013, Polymer Bulletin.

[76]  Shengrong Guo,et al.  Characterization of biodegradable and cytocompatible nano-hydroxyapatite/polycaprolactone porous scaffolds in degradation in vitro , 2010 .

[77]  Shen‐guo Wang,et al.  Enhanced cell affinity of poly (D,L-lactide) by combining plasma treatment with collagen anchorage. , 2002, Biomaterials.

[78]  P. Kasperska,et al.  Effect of poly(ε-caprolactone) as plasticizer on the properties of composites based on polylactide during hydrolytic degradation , 2016 .

[79]  W. Świȩszkowski,et al.  Delayed degradation of poly(lactide-co-glycolide) accelerates hydrolysis of poly(ε-caprolactone) in ternary composite scaffolds , 2016 .

[80]  G. Madras,et al.  Enzymatic degradation of poly (ε-caprolactone), poly (vinyl acetate) and their blends by lipases , 2003 .

[81]  Dietmar W. Hutmacher,et al.  Comparison of the degradation of polycaprolactone and polycaprolactone–(β‐tricalcium phosphate) scaffolds in alkaline medium , 2007 .

[82]  M. Natu,et al.  Influence of polymer processing technique on long term degradation of poly(ε-caprolactone) constructs , 2013 .

[83]  X. Loh The effect of pH on the hydrolytic degradation of poly(ε‐caprolactone)‐block‐poly(ethylene glycol) copolymers , 2013 .

[84]  J. Sarasua,et al.  Effects of chain microstructures on mechanical behavior and aging of a poly(L-lactide-co-ε-caprolactone) biomedical thermoplastic-elastomer. , 2012, Journal of the mechanical behavior of biomedical materials.

[85]  J. Cauich‐Rodríguez,et al.  Degradation studies on segmented polyurethanes prepared with HMDI, PCL and different chain extenders. , 2010, Acta biomaterialia.

[86]  D. Hutmacher,et al.  The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .

[87]  M. Vallet‐Regí,et al.  Alkaline-treated poly(ε-caprolactone) films: Degradation in the presence or absence of fibroblasts , 2006 .

[88]  S. Brocchini,et al.  Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass--polycaprolactone composites. , 2005, Biomaterials.

[89]  Z. Gu,et al.  In vitro enzymatic degradation of the cross-linked poly(ε-caprolactone) implants , 2015 .

[90]  M. Lebourg,et al.  Effects of hydroxyapatite filler on long-term hydrolytic degradation of PLLA/PCL porous scaffolds , 2015 .

[91]  C. X. Song,et al.  Synthesis and evaluation of biodegradable block copolymers of ε‐caprolactone and DL‐lactide , 1983 .

[92]  P. Vermette,et al.  Blends as a strategy towards tailored hydrolytic degradation of poly(ɛ-caprolactone-co-d,l-lactide)–poly(ethylene glycol)–poly(ɛ-caprolactone-co-d,l-lactide) co-polymers , 2008 .

[93]  Y. Doi,et al.  Thermal degradation of poly((R)-3-hydroxybutyrate), poly(e-caprolactone), and poly((S)-lactide) , 2002 .

[94]  D. Williams,et al.  Mechanisms of polymer degradation in implantable devices. I. Poly(caprolactone). , 1993, Biomaterials.

[95]  L. Cardon,et al.  Bulk mechanical properties of thermoplastic poly-e-caprolactone , 2014 .

[96]  J. Sarasua,et al.  In vitro degradation studies and mechanical behavior of poly(ε-caprolactone-co-δ-valerolactone) and poly(ε-caprolactone-co-L-lactide) with random and semi-alternating chain microstructures , 2015 .

[97]  K. Tuzlakoglu,et al.  Preparation and degradation of l-lactide and ε-caprolactone homo and copolymer films , 2002 .

[98]  B. Simionescu,et al.  Control and prediction of degradation of biopolymer based hydrogels with poly(ɛ-caprolactone) subunits. , 2014, International journal of biological macromolecules.

[99]  J. L. Feijoo,et al.  Abiotic degradation of poly(dl-lactide), poly(ɛ-caprolactone) and their blends , 2012 .

[100]  Dietmar W. Hutmacher,et al.  Design, fabrication and characterization of PCL electrospun scaffolds—a review , 2011 .

[101]  D. Untereker,et al.  Degradability of Polymers for Implantable Biomedical Devices , 2009, International journal of molecular sciences.

[102]  J. Acevedo,et al.  Poly(ε-caprolactone) Degradation Under Acidic and Alkaline Conditions , 2013 .

[103]  J. Mosnáček,et al.  Photochemically promoted degradation of poly(ɛ-caprolactone) film , 2013 .

[104]  Nuno M. Neves,et al.  Hydroxyapatite Reinforced Chitosan and Polyester Blends for Biomedical Applications , 2005 .

[105]  M. Xanthos,et al.  In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers. , 2007, Acta biomaterialia.

[106]  T. Aoyagi,et al.  Degradation of cross-linked aliphatic polyester composed of poly(ɛ-caprolactone-co-d,l-lactide) depending on the thermal properties , 2009 .

[107]  Lijian Liu,et al.  Lipase-catalyzed biodegradation of poly(ε-caprolactone) blended with various polylactide-based polymers , 2003 .

[108]  F. Moatamed,et al.  The intracellular degradation of poly(ε-caprolactone) , 1985 .

[109]  Z. Chen,et al.  In vitro and in vivo analysis of co-electrospun scaffolds made of medical grade poly(ε-caprolactone) and porcine collagen , 2008, Journal of biomaterials science. Polymer edition.

[110]  W. Thielemans,et al.  Synthesis of polycaprolactone: a review. , 2009, Chemical Society reviews.

[111]  M. Vallet‐Regí,et al.  Nitric oxide production by endothelial cells derived from blood progenitors cultured on NaOH-treated polycaprolactone films: A biofunctionality study. , 2009, Acta biomaterialia.

[112]  B. F. Matlaga,et al.  Ultrastructural observations of cells at the interface of a biodegradable polymer: Polyglactin 910. , 1983, Journal of biomedical materials research.

[113]  Stefan Lohfeld,et al.  Evaluating the effect of increasing ceramic content on the mechanical properties, material microstructure and degradation of selective laser sintered polycaprolactone/β-tricalcium phosphate materials. , 2015, Medical engineering & physics.

[114]  R. Ganesan,et al.  Lactobacillus sps. lipase mediated poly (ε-caprolactone) degradation. , 2017, International journal of biological macromolecules.

[115]  Sabu Thomas,et al.  Effect of zinc oxide nanoparticles on the in vitro degradation of electrospun polycaprolactone membranes in simulated body fluid , 2016 .

[116]  W. Wallace,et al.  Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery. , 2004, Biomaterials.

[117]  Scott J Hollister,et al.  Scaffold engineering: a bridge to where? , 2009, Biofabrication.

[118]  A. G. Pedroso,et al.  Evaluation of the thermal and mechanical properties of poly(ε-caprolactone), low-density polyethylene, and their blends , 2004 .

[119]  H. Tsuji,et al.  Blends of aliphatic polyesters. VI. Lipase-catalyzed hydrolysis and visualized phase structure of biodegradable blends from poly(epsilon-caprolactone) and poly(L-lactide). , 2001, International journal of biological macromolecules.

[120]  Yang-Hoon Kim,et al.  Immobilization of cross‐linked lipase aggregates onto magnetic beads for enzymatic degradation of polycaprolactone , 2010, Journal of basic microbiology.

[121]  G. Lewandowicz,et al.  Polymer Biodegradation and Biodegradable Polymers - a Review , 2010 .

[122]  Wim E. Hennink,et al.  New insights into the hydrolytic degradation of poly(lactic acid): participation of the alcohol terminus , 2001 .

[123]  V. Causin,et al.  Improvement of tensile properties and tuning of the biodegradation behavior of polycaprolactone by addition of electrospun fibers , 2011 .

[124]  Suming Li,et al.  Hydrolytic degradation of poly(DL-lactic acid) in the presence of caffeine base , 1996 .

[126]  D W Hutmacher,et al.  Three-Dimensional Bioprinting for Regenerative Dentistry and Craniofacial Tissue Engineering , 2015, Journal of dental research.

[127]  Cunxian Song,et al.  The in vivo degradation, absorption and excretion of PCL-based implant. , 2006, Biomaterials.

[128]  S. Teoh,et al.  Surface modification of PCL-TCP scaffolds in rabbit calvaria defects: Evaluation of scaffold degradation profile, biomechanical properties and bone healing patterns. , 2009, Journal of biomedical materials research. Part A.

[129]  Wim E Hennink,et al.  In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly(ε-caprolactone). , 2012, Biomaterials.

[130]  M. Slepian,et al.  Polymeric endoaortic paving: Mechanical, thermoforming, and degradation properties of polycaprolactone/polyurethane blends for cardiovascular applications. , 2011, Acta biomaterialia.

[131]  R. Kaushik,et al.  Poly-ϵ-caprolactone microspheres and nanospheres: an overview , 2004 .

[132]  M. Jenkins,et al.  The effect of crystalline morphology on the degradation of polycaprolactone in a solution of phosphate buffer and lipase , 2008 .

[133]  J. Sarasua,et al.  Effects of chain microstructures and derived crystallization capability on hydrolytic degradation of poly(l-lactide/ε-caprolactone) copolymers , 2013 .

[134]  Liqun Zhang,et al.  Structure, physical properties, biocompatibility and in vitro/vivo degradation behavior of anti-infective polycaprolactone-based electrospun membranes for guided tissue/bone regeneration , 2014 .

[135]  J. Kohn,et al.  Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. , 1991, Biomaterials.

[136]  S. Huang,et al.  The effects of primary structure on the degradation of poly(ɛ-caprolactone)/poly(l-lactide) block copolymers , 1998 .

[137]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[138]  Molly M Stevens,et al.  Melt-electrospun polycaprolactone strontium-substituted bioactive glass scaffolds for bone regeneration. , 2014, Journal of biomedical materials research. Part A.